2/12
07:59 am
rxrx
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
Medium
Report
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
2/8
07:15 pm
rxrx
Assessing Recursion Pharmaceuticals (RXRX) Valuation As Shares Trade Below Fair Value Estimate [Yahoo! Finance]
Neutral
Report
Assessing Recursion Pharmaceuticals (RXRX) Valuation As Shares Trade Below Fair Value Estimate [Yahoo! Finance]
1/29
07:29 pm
rxrx
Recursion Pharmaceuticals (RXRX) Declines More Than Market: Some Information for Investors [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals (RXRX) Declines More Than Market: Some Information for Investors [Yahoo! Finance]
1/29
09:54 am
rxrx
AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift [Globe and Mail, The (Toronto, Canada)]
Low
Report
AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift [Globe and Mail, The (Toronto, Canada)]
1/29
09:25 am
rxrx
AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift
Low
Report
AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift
1/24
07:11 pm
rxrx
Is Recursion Pharmaceuticals Inc. (RXRX) The Best Overlooked Penny Stock to Invest In? [Yahoo! Finance]
Low
Report
Is Recursion Pharmaceuticals Inc. (RXRX) The Best Overlooked Penny Stock to Invest In? [Yahoo! Finance]
1/20
10:26 am
rxrx
Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory [Yahoo! Finance]
1/18
12:41 pm
rxrx
JPMorgan Upgrades Recursion Pharmaceuticals, Inc. (RXRX) on FAP Treatment Prospects [Yahoo! Finance]
Medium
Report
JPMorgan Upgrades Recursion Pharmaceuticals, Inc. (RXRX) on FAP Treatment Prospects [Yahoo! Finance]
11/5/2025
06:30 am
RXRX
recursion pharmaceuticals, inc. - class a
BEAT
Report
1.6%
recursion pharmaceuticals, inc. - class a
8/5/2025
06:30 am
RXRX
recursion pharmaceuticals, inc. - class a
MISS
Report
-6.9%
recursion pharmaceuticals, inc. - class a
5/5/2025
06:00 am
RXRX
recursion pharmaceuticals, inc. - class a
MISS
Report
-15.5%
recursion pharmaceuticals, inc. - class a
2/28/2025
06:30 am
RXRX
recursion pharmaceuticals, inc. - class a
MISS
Report
-5.4%
recursion pharmaceuticals, inc. - class a
2/10
06:18 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Feb 06 Filed by: Taylor Ben R
Medium
Report
Form 4 RECURSION PHARMACEUTICAL For: Feb 06 Filed by: Taylor Ben R
2/10
06:18 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Feb 06 Filed by: Khan Najat
Medium
Report
Form 4 RECURSION PHARMACEUTICAL For: Feb 06 Filed by: Khan Najat
2/10
06:18 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Feb 06 Filed by: Hallett David
Medium
Report
Form 4 RECURSION PHARMACEUTICAL For: Feb 06 Filed by: Hallett David
2/6
05:54 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Feb 04 Filed by: Gibson Christopher
Neutral
Report
Form 4 RECURSION PHARMACEUTICAL For: Feb 04 Filed by: Gibson Christopher
2/6
05:53 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Feb 03 Filed by: Borgeson Blake
Neutral
Report
Form 4 RECURSION PHARMACEUTICAL For: Feb 03 Filed by: Borgeson Blake
2/5
10:04 am
rxrx
Form SCHEDULE 13G/A RECURSION PHARMACEUTICAL Filed by: BAILLIE GIFFORD & CO
Medium
Report
Form SCHEDULE 13G/A RECURSION PHARMACEUTICAL Filed by: BAILLIE GIFFORD & CO
2/4
09:50 am
rxrx
Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher
Medium
Report
Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher
2/3
11:38 am
rxrx
Form SCHEDULE 13G/A RECURSION PHARMACEUTICAL Filed by: ARK Investment Management LLC
Low
Report
Form SCHEDULE 13G/A RECURSION PHARMACEUTICAL Filed by: ARK Investment Management LLC
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register